RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $21,437,000 | 3.15% |
| COMMODORE CAPITAL LP | 178,565 | $5,727,000 | 3.11% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 451,612 | $14,483,000 | 1.25% |
| ACUTA CAPITAL PARTNERS, LLC | 120,000 | $3,848,000 | 1.05% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $6,414,000 | 0.98% |
| Avoro Capital Advisors LLC | 1,525,000 | $48,907,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,512,673 | $48,511,000 | 0.81% |
| Pegasus Asset Management, Inc. | 26,958 | $865,000 | 0.47% |
| HighVista Strategies LLC | 22,450 | $720,000 | 0.46% |
| Spotlight Asset Group, Inc. | 22,709 | $728,000 | 0.27% |